SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
Jan 20, 2016
Document Date
Jan 18, 2015
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
ReShape Lifesciences
Issuer
Filer
DeLange Peter M.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE